Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Wu, Wenjun
[Clear All Filters]
2023
Yang T
,
Jiang B
,
Luo Y
,
Zhao Y
,
Ouyang G
,
Yu J
,
Lan J
,
Lu Y
,
Lai X
,
Ye B
, et al.
Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms.
Am J Hematol. 2023.
PubMed
Google Scholar
Jin D
,
He J
,
Wu W
,
Han X
,
Le J
,
Shu W
,
Fu J
,
Kong H
,
Wang G
,
Zhou X
, et al.
Outcomes of COVID-19 in multiple myeloma patients treated with daratumumab.
Cancer Sci. 2023.
PubMed
Google Scholar
Hu Y
,
Zu C
,
Zhang M
,
Wei G
,
Li W
,
Fu S
,
Hong R
,
Zhou L
,
Wu W
,
Cui J
, et al.
Safety and efficacy of CRISPR-based non-viral locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study.
EClinicalMedicine. 2023;60:102010.
PubMed
Google Scholar
Wu L
,
Wu Y
,
Shi J
,
Lai X
,
Zhao Y
,
Liu L
,
Yu J
,
Yang L
,
Zhu P
,
Zheng W
, et al.
Survival and late mortality among patients who survived disease-free for 2 years after stem cell transplantation.
Br J Haematol. 2023.
PubMed
Google Scholar
2022
He D
,
Zhu C
,
Guo X
,
Huang X
,
Han X
,
Zheng G
,
Zhao Y
,
Yang Y
,
Wu W
,
Ge J
, et al.
The efficacy of residual plerixafor for second-day stem cell mobilization in multiple myeloma patients.
Transfus Apher Sci. 2022:103618.
PubMed
Google Scholar
2020
Qiu L
,
Zhu F
,
Wei G
,
Wu W
,
Yang L
,
Hu Y
,
Huang H
.
Idiopathic thrombocytopenic purpura treatment in a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T cell therapy.
Regen Ther. 2020;14:271-274.
PubMed
Google Scholar
Li X
,
Guo X
,
Zhu Y
,
Wei G
,
Zhang Y
,
Li X
,
Xu H
,
Cui J
,
Wu W
,
He J
, et al.
Single cell transcriptomic analysis reveals BCMA CAR-T cell dynamics in a patient with refractory primary plasma cell leukemia.
Mol Ther. 2020.
PubMed
Google Scholar